Researchers reveal molecular subtypes and new precise therapy for KRAS mutant cancers
Published Date: 8/10/2021
Source: phys.org
KRAS protein serves as an on/off molecular switch to relay signals from outside the cell to the cell nucleus. When the gene is mutated, KRAS will be continuously activated to promote the initiation and progression of cancers. It is one of the most commonly mutated genes, which approximately presents in 20% of all human cancers.